keyword
Keywords interstitial lung disease lung...

interstitial lung disease lung function

https://read.qxmd.com/read/38644448/explicate-molecular-landscape-of-combined-pulmonary-fibrosis-and-emphysema-through-explainable-artificial-intelligence-a-comprehensive-analysis-of-ild-and-copd-interactions-using-rna-from-whole-lung-homogenates
#1
JOURNAL ARTICLE
Nakul Tanwar, Yasha Hasija
Combined pulmonary fibrosis and emphysema (CPFE) presents a unique challenge in respiratory disorders, merging features of interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD). Using the random forest algorithm, our study thoroughly examines the molecular details of CPFE. Analyzing gene expression datasets from GSE47460 (ILD: 254, COPD: 220, control: 108), we identify key genes namely ADRB2, CDH3, IRS2, MATN3, CD38, PDIA4, VEGFC, and among twenty others, crucial in airway regulation, lung function, and apoptosis, shaping the complex pathogenesis of CPFE...
April 22, 2024: Medical & Biological Engineering & Computing
https://read.qxmd.com/read/38644266/-chinese-expert-consensus-on-the-management-of-clinical-pathway-and-adverse-events-of-trastuzumab-deruxtecan-2024-edition
#2
JOURNAL ARTICLE
(no author information available yet)
Trastuzumab deruxtecan (T-DXd) is one of the new generation antibody-drug conjugates (ADCs) targeting human epidermal growth factor receptor 2 (HER-2) with bystander effect. T-DXd can not only significantly improve the survival of HER-2-positive advanced breast cancer patients, but also enable advanced breast cancer patients with low HER-2 expression to benefit from HER-2-targeted therapy. T-DXd has been approved by the National Medical Products Administration (NMPA) for the treatment of HER-2-positive or HER-2-low breast cancer patients...
April 23, 2024: Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology]
https://read.qxmd.com/read/38642252/association-between-anti-pl7-antibodies-and-increased-fibrotic-component-in-patients-with-antisynthetase-syndrome-and-interstitial-lung-disease-a-cross-sectional-study
#3
JOURNAL ARTICLE
Daphne Rivero-Gallegos, Mayra Mejía, Héctor I Rocha-González, Juan C Huerta-Cruz, Ramcés Falfán-Valencia, Espiridion Ramos-Martínez, Heidegger N Mateos-Toledo, María F Castillo-López, Yeimi K Rodríguez-Torres, Valeria Lira-Boussart, Jorge Rojas-Serrano
OBJECTIVE: To evaluate whether anti-PL7 and anti-PL12 autoantibodies are associated with a greater extent of the fibrotic component of ILD in ASSD patients. METHODS: Patients with ILD-ASSD who were positive for one of the following autoantibodies: anti-Jo1, anti-PL7, anti-PL12, and anti-EJ were included. Clinical manifestations, CPK levels, pulmonary function tests, and HCRT assessments were prospectively collected according to the Goh index. The fibrotic, inflammatory, and overall extension of the Goh index and DLCO were assessed by multiple linear analyses and compared between ASSD antibody subgroups...
April 20, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38633577/fapi-pet-ct-for-assessment-and-visualisation-of-active-myositis-related-interstitial-lung-disease-a-prospective-observational-pilot-study
#4
JOURNAL ARTICLE
Kastriot Kastrati, Thomas S Nakuz, Oana C Kulterer, Irina Geßl, Elisabeth Simader, Daniel Mrak, Michael Bonelli, Hans Peter Kiener, Florian Prayer, Helmut Prosch, Daniel Aletaha, Werner Langsteger, Tatjana Traub-Weidinger, Stephan Blüml, Helga Lechner-Radner, Marcus Hacker, Peter Mandl
BACKGROUND: Interstitial lung disease (ILD) is a common manifestation of idiopathic inflammatory myopathies (IIM) and a substantial contributor to hospitalisation, increased morbidity, and mortality. In-vivo evidence of ongoing tissue remodelling in IIM-ILD is scarce. We aimed to evaluate fibroblast activation in lungs of IIM-patients and control individuals using ⁶⁸Ga-labelled inhibitor of Fibroblast-Activation-Protein (FAPi) based positronic emission tomography and computed tomography imaging (PET/CT)...
June 2024: EClinicalMedicine
https://read.qxmd.com/read/38633306/microbiome-features-in-bronchoalveolar-lavage-fluid-of-patients-with-idiopathic-inflammatory-myopathy-related-interstitial-lung-disease
#5
JOURNAL ARTICLE
Liyan Zhang, Xueqing Liu, Bijun Fan, Jiajun Chen, Jie Chen, Qiuhong Li, Xueling Wu
BACKGROUND: Interstitial lung disease (ILD) is a common complication of idiopathic inflammatory myopathy (IIM), which is one of the connective tissue diseases (CTD). It can lead to poor prognosis and increased mortality. However, the distribution and role of the lower respiratory tract (LRT) microbiome in patients with IIM-ILD remains unclear. This study aimed to investigate the microbial diversity and community differences in bronchoalveolar lavage fluid (BALF) in patients with IIM-ILD...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38630364/sirtuins-and-cellular-senescence-in-patients-with-idiopathic-pulmonary-fibrosis-and-systemic-autoimmune-disorders
#6
REVIEW
Vito D'Agnano, Domenica Francesca Mariniello, Raffaella Pagliaro, Mehrdad Savabi Far, Angela Schiattarella, Filippo Scialò, Giulia Stella, Maria Gabriella Matera, Mario Cazzola, Andrea Bianco, Fabio Perrotta
The sirtuin family is a heterogeneous group of proteins that play a critical role in many cellular activities. Several degenerative diseases have recently been linked to aberrant sirtuin expression and activity because of the involvement of sirtuins in maintaining cell longevity and their putative antiaging function. Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis associated with systemic autoimmune disorders are severe diseases characterized by premature and accelerated exhaustion and failure of alveolar type II cells combined with aberrant activation of fibroblast proliferative pathways leading to dramatic destruction of lung architecture...
April 17, 2024: Drugs
https://read.qxmd.com/read/38625791/endothelial-cell-expression-of-a-sting-gain-of-function-mutation-initiates-pulmonary-lymphocytic-infiltration
#7
JOURNAL ARTICLE
Kevin MingJie Gao, Kristy Chiang, Zhaozhao Jiang, Filiz T Korkmaz, Harish P Janardhan, Chinmay M Trivedi, Lee J Quinton, Sebastien Gingras, Katherine A Fitzgerald, Ann Marshak-Rothstein
Patients afflicted with Stimulator of interferon gene (STING) gain-of-function mutations frequently present with debilitating interstitial lung disease (ILD) that is recapitulated in mice expressing the STINGV154M mutation (VM). Prior radiation chimera studies revealed an unexpected and critical role for non-hematopoietic cells in initiating ILD. To identify STING-expressing non-hematopoietic cell types required for the development of ILD, we use a conditional knockin (CKI) model and direct expression of the VM allele to hematopoietic cells, fibroblasts, epithelial cells, or endothelial cells...
April 15, 2024: Cell Reports
https://read.qxmd.com/read/38619119/serum-levels-of-aggf1-potential-association-with-cutaneous-and-cardiopulmonary-involvements-in-systemic-sclerosis
#8
JOURNAL ARTICLE
Takuya Takahashi, Takehiro Takahashi, Tetsuya Ikawa, Hitoshi Terui, Toshiya Takahashi, Yuichiro Segawa, Hayakazu Sumida, Ayumi Yoshizaki, Shinichi Sato, Yoshihide Asano
Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy, aberrant immune activation, and extensive tissue fibrosis of the skin and internal organs. Because of the complicated nature of its pathogenesis, the underlying mechanisms of SSc remain incompletely understood. Angiogenic factor with a G-patch domain and a Forkhead-associated domain 1 (AGGF1) is a critical factor in angiogenesis expressed on vascular endothelial cells, associated with inflammatory and fibrotic responses. To elucidate the possible implication of AGGF1 in SSc pathogenesis, we investigated the association between serum AGGF1 levels and clinical manifestations in SSc patients...
April 15, 2024: Journal of Dermatology
https://read.qxmd.com/read/38618336/history-is-the-key-to-diagnosis-a-case-of-nitrofurantoin-induced-interstitial-lung-disease
#9
Kristina Akopyan, Raaed Zafar, Ibrahim Faruqi
We present the case of a 74-year-old woman with a past medical history (PMH) significant for anxiety, depression, and hypertension who presented to the pulmonary clinic for consultation regarding progressive shortness of breath, which started five months ago after developing COVID-19. Further history-taking revealed that she had been started on nitrofurantoin two months ago for recurrent urinary tract infections (UTIs). Her pulmonary function tests (PFTs) demonstrated a moderately restrictive disease. A CT chest was obtained, showing pleural thickening with bilateral pleural-based ground glass opacities...
March 2024: Curēus
https://read.qxmd.com/read/38617767/wedge-resection-segmentectomy-and-lobectomy-oncologic-outcomes-based-on-extent-of-surgical-resection-for-%C3%A2-2-cm-stage-ia-non-small-cell-lung-cancer
#10
JOURNAL ARTICLE
Shaikha Al-Thani, Abu Nasar, Jonathan Villena-Vargas, Sebron Harrison, Benjamin Lee, Jeffrey L Port, Nasser Altorki, Oliver S Chow
BACKGROUND: Long-standing controversy has existed over whether sublobar resection is an adequate oncological procedure for clinical stage IA non-small cell lung cancer (NSCLC) ≤2 cm, despite the recent randomized trial reports of Japanese Clinical Oncology Group (JCOG) 0802 and Cancer and Leukemia Group B (CALGB) 140503 demonstrating non-inferior outcomes with sublobar resection compared to lobectomy. As practice patterns shift, we sought to compare oncologic outcomes in patients with these early-stage tumors after wedge resection, segmentectomy, or lobectomy in a contemporary, real-world, cohort...
March 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38614796/chest-ct-features-and-functional-correlates-of-covid-19-at-3-months-and-12-months-follow-up
#11
JOURNAL ARTICLE
Kartik Kumar, Ratnaprashanthika Ratnakumar, Simon M Collin, Luis C Berrocal-Almanza, Piera Ricci, Mustafa Al-Zubaidy, Robina K Coker, Meg Coleman, Sarah L Elkin, Patrick Mallia, Jamilah Meghji, Clare Ross, Georgina K Russell, Katie Ward, Melissa Wickremasinghe, Sarah Sheard, Susan J Copley, Onn Min Kon
Long-term pulmonary sequelae of Coronavirus 2019 (COVID-19) remain unclear. Thus, we aimed to establish post-COVID-19 temporal changes in chest computed tomography (CT) features of pulmonary fibrosis and to investigate associations with respiratory symptoms and physiological parameters at 3 and 12 months' follow-up. Adult patients who attended our initial COVID-19 follow-up service and developed chest CT features of interstitial lung disease, in addition to cases identified using British Society of Thoracic Imaging codes, were evaluated retrospectively...
September 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38610791/the-beneficial-impact-of-pulmonary-rehabilitation-in-idiopathic-pulmonary-fibrosis-a-review-of-the-current-literature
#12
REVIEW
Stefano Sanduzzi Zamparelli, Carmen Lombardi, Claudio Candia, Paola Rebecca Iovine, Gaetano Rea, Michele Vitacca, Pasquale Ambrosino, Marialuisa Bocchino, Mauro Maniscalco
Idiopathic pulmonary fibrosis (IPF) is a chronic and irreversible fibrotic disease whose natural history is characterised by a progressive worsening of the pulmonary function, exertional dyspnoea, exercise intolerance, reduced physical activity, and health-related quality of life (HRQOL) impairment. Pulmonary rehabilitation (PR) is a comprehensive, multi-disciplinary programme that uses a combination of strength training, teaching, counselling, and behaviour modification techniques to reduce symptoms and optimise functional capacity in patients with chronic lung disease...
March 30, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38605950/rate-of-severe-and-fatal-infections-in-a-cohort-of-patients-with-interstitial-lung-disease-associated-with-rheumatoid-arthritis-a-multicenter-prospective-study
#13
MULTICENTER STUDY
Natalia Mena-Vázquez, Rocío Redondo-Rodriguez, Marta Rojas-Gimenez, Carmen María Romero-Barco, Clara Fuego-Varela, Nair Perez-Gómez, Isabel Añón-Oñate, Patricia Castro Pérez, Aimara García-Studer, Ana Hidalgo-Conde, Rocío Arnedo Díez de Los Ríos, Eva Cabrera-César, Maria Luisa Velloso-Feijoo, Sara Manrique-Arija, Jerusalem Calvo-Gutiérrez, Myriam Gandía-Martínez, Pilar Morales-Garrido, Francisco Javier Godoy-Navarrete, Coral Mouriño-Rodriguez, Francisco Espildora, María Carmen Aguilar-Hurtado, Antonio Fernández-Nebro
OBJECTIVE: To describe severe infection, foci of infection, microorganisms, associated factors, and impact on mortality in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). PATIENTS AND METHODS: The study was based on a multicenter prospective cohort of patients with RA-ILD followed up from 2015 to 2023. The main outcome measures were incident severe infection and fatal infection. We evaluated infectious foci, etiologic agents, vaccination status, variables associated with lung function, and clinical-therapeutic variables in RA...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38603946/selenite-selectively-kills-lung-fibroblasts-to-treat-bleomycin-induced-pulmonary-fibrosis
#14
JOURNAL ARTICLE
Jiun-Han Lin, Chen-Chi Liu, Chao-Yu Liu, Tien-Wei Hsu, Yi-Chen Yeh, Chorng-Kuang How, Han-Shui Hsu, Shih-Chieh Hung
BACKGROUND: Interstitial lung disease (ILD) treatment is a critical unmet need. Selenium is an essential trace element for human life and an antioxidant that activates glutathione, but the gap between its necessity and its toxicity is small and requires special attention. Whether selenium can be used in the treatment of ILD remains unclear. METHODS: We investigated the prophylactic and therapeutic effects of selenite, a selenium derivative, in ILD using a murine model of bleomycin-induced idiopathic pulmonary fibrosis (IPF)...
April 5, 2024: Redox Biology
https://read.qxmd.com/read/38599818/-primary-antibody-deficiencies-and-respiratory-manifestations-in-adults
#15
JOURNAL ARTICLE
J C Zhong, L W Wang
Primary antibody deficiencies (PAD) are a group of congenital disorders caused by genetic defects that affect the development and function of the body's immune defence mechanisms. Patients with PAD may present with recurrent infections, lymphoproliferation, autoimmune diseases, autoinflammation, or malignancies. Respiratory system manifestations may include bronchiectasis, bronchial asthma, and interstitial lung disease, among others. A comprehensive understanding of PADs will help to distinguish these covert cases from more common respiratory diseases...
April 12, 2024: Chinese Journal of Tuberculosis and Respiratory Diseases
https://read.qxmd.com/read/38589291/serum-ccl24-as-a-biomarker-of-fibrotic-and-vascular-disease-severity-in-systemic-sclerosis
#16
JOURNAL ARTICLE
Enrico De Lorenzis, Adi Mor, Rebecca L Ross, Stefano Di Donato, Revital Aricha, Ilan Vaknin, Francesco Del Galdo
BACKGROUND: Systemic sclerosis (SSc) is a heterogeneous disease, characterized by variable tissue and vascular fibrosis in the context of autoimmune activation. The C-C Motif Chemokine Ligand 24 (CCL24 or Eotaxin2) has been shown to promote microangiopathic, pro-inflammatory, and pro-fibrotic processes in preclinical models of SSc. Here we study serum CCL24 levels in a real-life cohort of SSc patients, to determine its distribution across disease features and its value in predicting disease progression and related mortality...
April 8, 2024: Arthritis Care & Research
https://read.qxmd.com/read/38586742/secondary-spontaneous-pneumothorax-in-a-patient-with-interstitial-lung-disease-undergoing-routine-outpatient-pulmonary-function-tests
#17
Kristina Akopyan, Raaed Zafar, Ibrahim Faruqi
We present the case of a 64-year-old female with a past medical history significant for unclassified interstitial lung disease (ILD) from suspected hypersensitivity pneumonitis secondary to chronic mold exposure with steroid responsiveness and prior pneumothorax. The patient developed shortness of breath and pleuritic chest pain after undergoing routine outpatient pulmonary function tests (PFTs). She was immediately transferred to the emergency department and found to have a moderate left basilar pneumothorax...
March 2024: Curēus
https://read.qxmd.com/read/38584853/experiences-of-systemic-sclerosis-patients-with-home-monitoring-of-their-pulmonary-function-a-qualitative-study
#18
JOURNAL ARTICLE
Arthiha Velauthapillai, Gwyn M M Schepers, Madelon C Vonk, Cornelia H M van den Ende
OBJECTIVE: To evaluate the experiences, perceived benefits and disadvantages of home monitoring of pulmonary function in SSc patients with interstitial lung disease (ILD). METHODS: Semistructured interviews were conducted among SSc-ILD patients who used the home monitoring application of pulmonary function for at least 3 months. In our program, patients are instructed to perform home spirometry weekly at fixed time points using a mobile application with results being directly visible for patients and physicians...
2024: Rheumatology Advances in Practice
https://read.qxmd.com/read/38583585/blood-oxygenation-state-in-covid-19-patients-unexplored-role-of-2-3-bisphosphoglycerate
#19
JOURNAL ARTICLE
Maria Sofia Bertilacchi, Rebecca Piccarducci, Alessandro Celi, Lorenzo Germelli, Chiara Romei, Brian Bartholmai, Greta Barbieri, Chiara Giacomelli, Claudia Martini
BACKGROUND: COVID-19 reduces lung functionality causing a decrease of blood oxygen levels (hypoxemia) often related to a decreased cellular oxygenation (hypoxia). Besides lung injury, other factors are implicated in the regulation of oxygen availability such as pH, partial arterial carbon dioxide tension (PaCO2 ), temperature, and erythrocytic 2,3-bisphosphoglycerate (2,3-BPG) levels, all factors affecting hemoglobin saturation curve. However, few data are currently available regarding the 2,3-BPG modulation in SARS-CoV-2 affected patients at the hospital admission...
April 5, 2024: Biomedical Journal
https://read.qxmd.com/read/38581478/volume-changes-of-diseased-and-normal-areas-in-progressive-fibrosing-interstitial-lung-disease-on-inspiratory-and-expiratory-computed-tomography
#20
JOURNAL ARTICLE
Taiga Kobayashi, Yoshie Kunihiro, Takuya Uehara, Masahiro Tanabe, Katsuyoshi Ito
PURPOSE: The diagnosis of progressive fibrosing interstitial lung disease (PF-ILD) using computed tomography (CT) is an important medical practice in respiratory care, and most imaging findings for this disease have been obtained with inspiratory CT. It is possible that some characteristic changes in respiration may be seen in normal and diseased lung in PF-ILD, which may lead to a new understanding of the pathogenesis of interstitial pneumonia, but it has never been examined. In this study, we collected and selected inspiratory and expiratory CT scans performed in pure PF-ILD cases, and evaluated the volumes of diseased and normal lung separately by manual detection and 3-dimensional volumetry to characterize the dynamic features of PF-ILD...
April 6, 2024: Japanese Journal of Radiology
keyword
keyword
119108
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.